BSE filing, NSE: ICVLSTEELS. Summary written from the filing by ALFA Finder's alert engine.
Aerpace Industries Ltd: key numbers
- Share price
- ₹38.30
- Market cap
- ₹572.6 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹-15.17 Cr
- P/E (TTM)
- -27.9×Sector 16.9×
- Promoter holding
- 44.85%-0.40% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aerpace Industries Ltd
All →Aerpace Industries Q2 FY27 Results: Net Loss of ₹5.9 Cr, Loss Widens
Aerpace Industries Ltd reported a net loss of ₹5.9 Cr for Q2 FY27.
- Key figure
- Net loss ₹5.9 Cr
Aerpace Industries Other Announcement
Aerpace Industries Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31(1)(b). This is a routine regulatory filing.
Aerpace Industries Board Meeting Date
Aerpace Industries Limited has scheduled a board meeting for October 19, 2026, to consider and approve its unaudited financial results for the quarter.
Aerpace Industries Capital Structure Change
N.K. Family Private Trust, a promoter entity, acquired 1,50,00,000 warrants of Aerpace Industries Limited. This acquisition was conducted via a preferential allotment on September 26, 2026.
Aerpace Industries Annual General Meeting
Aerpace Industries Limited held its 15th Annual General Meeting on September 30, 2026, where members transacted various ordinary and special business resolutions.
Aerpace Industries Capital Structure Change
Aerpace Industries allotted 1.50 Crore convertible warrants on a preferential basis to the promoter group, aggregating Rs. 48.83 Crore for the total issue.
- Value
- ₹48.83 Cr
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.